FDA Announces Plan to Advance Biotech Innovation

FDA announced a new plan to advance plant and animal biotechnology innovation, FDA Commissioner Scott Gottlieb and Deputy Commissioner Anna Abram said in an Oct. 30, 2018 statement. The agency’s Plant and Animal Biotechnology Innovation Action Plan explains how FDA will clarify its science-and-risk-based approach to product development and support innovation while advancing safety and its public health mission.

Read more